BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 30636596)

  • 1. Clinical Characteristics and Antibiotic Resistance of Mycoplasma Pneumoniae Pneumonia in Hospitalized Chinese Children.
    Yuan C; Min FM; Ling YJ; Li G; Ye HZ; Pan JH; Wang L; Xie YP
    Comb Chem High Throughput Screen; 2018; 21(10):749-754. PubMed ID: 30636596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
    Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
    Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An adult case of severe life-threatening Mycoplasma pneumoniae pneumonia due to a macrolide-resistant strain, Japan: a case report.
    Matsumoto M; Nagaoka K; Suzuki M; Konno S; Takahashi K; Takashina T; Ishiguro N; Nishimura M
    BMC Infect Dis; 2019 Feb; 19(1):204. PubMed ID: 30819124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
    Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility and genotyping of
    Zhao F; Liu J; Shi W; Huang F; Liu L; Zhao S; Zhang J
    Antimicrob Resist Infect Control; 2019; 8():18. PubMed ID: 30697421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiologic findings as a determinant and no effect of macrolide resistance on clinical course of Mycoplasma pneumoniae pneumonia.
    Yoon IA; Hong KB; Lee HJ; Yun KW; Park JY; Choi YH; Kim WS; Lee H; Eun BW; Ahn YM; Cho EY; Cho HJ; Choi EH
    BMC Infect Dis; 2017 Jun; 17(1):402. PubMed ID: 28592263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of drug resistance of Mycoplasma pneumoniae with DNA load and genotypes in children with Mycoplasma pneumoniae pneumonia].
    Zhang HF; Bai HT; Li JM; Xie H; Wang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Nov; 19(11):1180-1184. PubMed ID: 29132466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility and molecular characteristics of
    Zhao F; Li J; Liu J; Guan X; Gong J; Liu L; He L; Meng F; Zhang J
    Antimicrob Resist Infect Control; 2019; 8():143. PubMed ID: 31463046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China.
    Liu Y; Ye X; Zhang H; Xu X; Li W; Zhu D; Wang M
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):355-8. PubMed ID: 20638604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Detection and Characterization of Macrolide-Resistant
    Noori Goodarzi N; Pourmand MR; Arfaatabar M; Azimi G; Masoorian E; Rahimi Foroushani A; Aminharati F; Heidarzadeh S; Baghani A
    Microb Drug Resist; 2020 Mar; 26(3):245-250. PubMed ID: 31545147
    [No Abstract]   [Full Text] [Related]  

  • 12. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro.
    Okazaki N; Narita M; Yamada S; Izumikawa K; Umetsu M; Kenri T; Sasaki Y; Arakawa Y; Sasaki T
    Microbiol Immunol; 2001; 45(8):617-20. PubMed ID: 11592636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
    Kawai Y; Miyashita N; Kubo M; Akaike H; Kato A; Nishizawa Y; Saito A; Kondo E; Teranishi H; Ogita S; Tanaka T; Kawasaki K; Nakano T; Terada K; Ouchi K
    Antimicrob Agents Chemother; 2013 May; 57(5):2252-8. PubMed ID: 23459497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.
    Liu Y; Ye X; Zhang H; Wu Z; Xu X
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):333-7. PubMed ID: 24503503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrolide-resistant Mycoplasma pneumoniae in adults in Zhejiang, China.
    Zhou Z; Li X; Chen X; Luo F; Pan C; Zheng X; Tan F
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1048-51. PubMed ID: 25451048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrolide resistance of
    Jiang Y; Dou H; Xu B; Xu B; Zhou W; Wang H; Ge L; Hu Y; Han X; Qin X; Li J; Ye L; Wu L; Zuo H; Zhang Q; Liu L; Hu W; Shao J; Yin Q; Han L; Fu X; Dong X; Dong Y; Fu Y; Zhao M; Sun Q; Huo J; Liu D; Liu W; Li Y; Wang Y; Xin D; Shen K
    Epidemiol Infect; 2024 Apr; 152():e75. PubMed ID: 38634450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
    Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.
    Dumke R; Stolz S; Jacobs E; Juretzek T
    Int J Infect Dis; 2014 Dec; 29():197-9. PubMed ID: 25449256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Macrolide resistance in Mycoplasma pneumoniae by recurrence and extended illness].
    Uldum SA; Amberg P; Jensen JS
    Ugeskr Laeger; 2012 Mar; 174(11):730-1. PubMed ID: 22409896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan.
    Matsuoka M; Narita M; Okazaki N; Ohya H; Yamazaki T; Ouchi K; Suzuki I; Andoh T; Kenri T; Sasaki Y; Horino A; Shintani M; Arakawa Y; Sasaki T
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4624-30. PubMed ID: 15561835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.